← Back to Search

Behavioural Intervention

Text-Based Smoking Cessation Program for Quitting Smoking

N/A

Recruiting

Led By Irene Tami-Maury, DMD,MSc,DrPH-NHSN

Research Sponsored by The University of Texas Health Science Center, Houston

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Have smoked at least 100 cigarettes in their lifetime, smoke every day, and smoke greater than or equal to 5 cigarettes a day

Have a cell phone number with an unlimited short message service (SMS) plan

Timeline

Screening 3 weeks

Treatment Varies

Follow Up end of month 6

Awards & highlights

Study Summary

This trial tests an SGM-specific program to help sexual/gender minorities quit smoking. It checks how effective & acceptable it is.

Who is the study for?

This trial is for LGBTQ+ individuals who want to quit smoking, smoke at least 5 cigarettes daily, and have smoked over 100 in their lifetime. They must live in Texas, have a cell phone with unlimited texting, and test positive for nicotine use. Excluded are non-English speakers, those on cessation meds or prepaid phones, pregnant/breastfeeding persons, and people with certain medical conditions.Check my eligibility

What is being tested?

The study is evaluating SmokefreeSGM—a tailored text messaging program designed to help sexual and gender minority groups quit smoking—against the standard SmokefreeTXT program. Participants will receive supportive texts aimed at aiding smoking cessation.See study design

What are the potential side effects?

Since this trial involves text-based interventions without medications or invasive procedures, there are no direct physical side effects expected from participation. However, participants may experience stress or anxiety related to quitting smoking.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have smoked more than 100 cigarettes in my life and currently smoke 5 or more daily.

Select...

I have a cell phone with unlimited texting.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ end of month 6

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~end of month 6

This trial's timeline: 3 weeks for screening, Varies for treatment, and end of month 6 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Feasibility as assessed by number of participants recruited for the study

Feasibility as assessed by number of participants that completed month 1 visit

Feasibility as assessed by number of participants that completed month 3 visit

+2 more

Secondary outcome measures

Acceptability as assessed by qualitative interviews

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: SmokefreeSGMExperimental Treatment1 Intervention

Group II: SmokefreeTXTActive Control1 Intervention

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

SmokefreeSGM

2022

N/A

~20

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center, HoustonLead Sponsor

903 Previous Clinical Trials

320,897 Total Patients Enrolled

National Cancer Institute (NCI)NIH

13,654 Previous Clinical Trials

40,933,073 Total Patients Enrolled

Irene Tami-Maury, DMD,MSc,DrPH-NHSNPrincipal InvestigatorThe University of Texas Health Science Center, Houston

Media Library

SmokefreeSGM (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05645354 — N/A

Smoking Cessation Research Study Groups: SmokefreeSGM, SmokefreeTXT

Smoking Cessation Clinical Trial 2023: SmokefreeSGM Highlights & Side Effects. Trial Name: NCT05645354 — N/A

SmokefreeSGM (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05645354 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an opportunity to join this clinical research endeavor currently?

"According to the particulars on clinicaltrials.gov, recruitment for this trail is in progress with an initial posting date of November 10th 2022 and a most recent update dated December 1st 2022."

Answered by AI

How many subjects are being examined in this investigation?

"Affirmative. According to details posted on clinicaltrials.gov, this medical trial is presently recruiting patients and was initially published on November 10th 2022. 80 individuals have been requested from the sole participating site with updates being provided as recently as December 1st 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

SmokefreeSGM, A Text-based Smoking Cessation Feasibility Trial for Sexual and Gender Minority Groups

Irene Tami-Maury 2022. "SmokefreeSGM, A Text-based Smoking Cessation Feasibility Trial for Sexual and Gender Minority Groups". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05645354.

All > Smoking Cessation